NCT03875222

Brief Summary

study for discovering new criteria for localization of site of accessory pathway from surface ECG

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2019

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 14, 2019

Completed
18 days until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2021

Completed
Last Updated

March 19, 2019

Status Verified

March 1, 2019

Enrollment Period

2 years

First QC Date

March 13, 2019

Last Update Submit

March 16, 2019

Conditions

Accessory Pathway

Outcome Measures

Primary Outcomes (1)

  • percise localization of accessory pathway from surface ECG in referance to successful ablation site

    successful localization of accessory pathway from surface ECG in referance to successful ablation site during EP maping

    2 years

Eligibility Criteria

Age10 Years - 90 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

any patient with manifest accessory pathway between 10 and 90 years of age undergoing EP maping and ablation.

You may qualify if:

  • any patient with manifest accessory pathway .

You may not qualify if:

  • multiple accessory pathways .previous ablation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pre-Excitation Syndromes

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System Disease

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

March 13, 2019

First Posted

March 14, 2019

Study Start

April 1, 2019

Primary Completion

April 1, 2021

Study Completion

August 1, 2021

Last Updated

March 19, 2019

Record last verified: 2019-03